Thiel Foundation

Kisan Network is a tech-enabled supply chain startup focused on agriculture. It is an enabled and fully integrated PAN India Agri produce supply chain connecting marginal farmers directly to businesses. The company started in 2016 and is headquartered in Gurgaon, Haryana, India.

Teal Drones build our own hardware and software drone platforms for Consumer and Enterprise applications. Teal One, our flagship product, is one of the highest performing drones in the market, offering an incredible flight experience to users, premium hardware and design, and a software platform that fuels innovation.

Envisagenics focus on the discovery of RNA therapeutics. Their mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors, and more remain to be discovered. Their breakthrough technology, SpliceCore, is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data, using Artificial Intelligence. We are using our software to identify splicing errors causative of diseases, identify the right drug targets, and develop RNA therapeutics through partnerships and collaborations with Biopharma. Their in-silico RNA therapeutics discovery platform replaces expensive drug-target selection and lead design with efficient computer simulations, decreasing time, cost, and failure risk of drug development programs. Envisagenics was founded in 2014 as a spinout of Cold Spring Harbor Laboratory.

Cafe X Technologies is focused on increasing productivity in the service industry through automation. Cafe X Technologies is a privately backed company with funding from Khosla Ventures, Social Capital, Jason Calacanis, Felicis Ventures, Silicon Valley Bank, and The Thiel Foundation.

Kisan Network is a tech-enabled supply chain startup focused on agriculture. It is an enabled and fully integrated PAN India Agri produce supply chain connecting marginal farmers directly to businesses. The company started in 2016 and is headquartered in Gurgaon, Haryana, India.

Sweet is a service designed to help individuals reduce their mobile phone bills without compromising on coverage quality. The company identifies instances where users are overpaying for wireless services, with customers saving an average of over $300 annually. The sign-up process is quick and straightforward, allowing users to engage with the service in just seconds. Sweet manages interactions with mobile carriers on behalf of its customers, minimizing the effort required on their part. The company prioritizes user privacy and security, employing advanced encryption technology to protect personal information. Offering nationwide coverage, Sweet collaborates with major carriers to ensure reliable service and fast connection speeds. The company is supported by experienced entrepreneurs from reputable organizations, enhancing its credibility and operational capacity.

We empower humans to edit and clip videos, while at the same time gather data to train AI - check out our API: http://docs.gifs.com

Fountain is high-volume hiring because its solutions enable customers to get ahead of their hiring goals.

HoneyInsured is Hipmunk for health insurance. You answer 4 one-click questions, get a plan recommendation, and enroll in 5 minutes.

Magin is an iPhone email app that tries to improve where other similar apps fall short by providing unique user interface, combined with cool features. The app tries to focus on most of the key things in email and makes them better by providing user experience that will make your actions seem fast and fluid. The app also tries to incorporate gestures and hand movements to excel the user experience, and combine these with unique animations that makes the interface to look lively and attractive. Being in such a crowded space Magin tries to differentiate from it's competitors by combining unique user interface with great features and aims to boost your productivity, whereas other similar apps are trying to "just work", Magin make it all seem like magic.

Data is full of important insights that are never discovered because they are too difficult and expensive to find. Except for the most routine cases, hunting for these insights requires grappling with complex, difficult-to-learn interfaces or tedious programming. Questions about data that take moments to formulate can take hours or much longer to answer. SkyPhrase aims to change this. With SkyPhrase, you can pose a question in simple natural language, and our artificial intelligence technology will figure out what you mean, and how to answer. Our goal is to make it easy to use all data this simply. Our web analytics and football statistics services are early steps towards achieving this goal. At SkyPhrase, our approach to natural language understanding is different because of our goals and because of our technology. We focus on giving people significantly more power over their data in specific areas, and allowing developers to easily add support to other areas. Within these areas, our technology can understand significantly more complex language with greater precision than any other technology. While we currently only cover web analytics and football statistics, our technology makes it extremely simple and easy for developers with little knowledge of linguistics or artificial intelligence to create natural language interfaces to their own data and applications. Our technology has been developed by scientists with decades of experience in artificial intelligence and computational linguistics research at institutions such as MIT, Stanford and Rensselaer. If you have a data set or API you would like to access with natural language, let us know. Stay tuned as we expand SkyPhrase to more areas, make it more powerful and enable third parties to use our technology for their own data and applications.

Siva Therapeutics develops cancer therapies that improve patient outcomes. They develop safe, minimally-invasive, practical, and cost-effective medical device treatments for cancer using proprietary technologies. The company's therapy generates therapeutic heat within solid tumors using gold nanorods and an infrared light device which is more selective than chemotherapy, less destructive than radiation, and without the risks of surgery.

Positron Dynamics LLC was founded in 2011 by Ryan Weed and Joshua Machacek. Our area of expertise is in the use of ‘cold’ positrons as a diagnostic for materials and in low-energy collisions with atoms and molecules. The company develops positron beam technologies for use in non-destructive testing (NDT) of critical components in the aerospace and defense markets. At the heart of these technologies is a novel method of producing and moderating positrons, for which several patents were awarded in 2011.

Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.

Inspirotec LLC, a Chicago, IL-based company that develops a universal system for collecting and identifying airborne agents.

3Scan is turning tissue into bits by building robotic microscopy tools and software for large-scale sample analysis and 3D visualizations. Many diseases emerge only at a tissue level, such as cancer, heart disease, lung disease, stroke, Alzheimer's, and diabetes. 3Scan enables higher throughput, greater quantification, and broader image analysis than what is currently possible with traditional histopathology. 3Scan's data-driven approach is expanding our understanding of tissue biology and will lead to the discovery of new diagnostics and therapeutics. The company was founded in 2011 and is headquartered in San Francisco, California.

Immusoft is a biotechnology company that is commercializing technology to program the human immune system by modifying the DNA in immune cells. The core components of Immusoft’s Immune System Programming (ISP) technology was developed in the Baltimore Lab at the California Institute of Technology (Caltech) and exclusively licensed by Immusoft. The technology instructs a patient’s cells to produce gene-encoded medicines (biologics). Cells that are reprogrammed using ISP become miniature drug factories that are expected to survive in patients for many years. It was founded in 2009 and is headquartered in Seattle, Washington.